A multimodal machine learning model for predicting dementia conversion in Alzheimer’s disease

Min Woo Lee, Hye Weon Kim, Yeong Sim Choe, Hyeon Sik Yang, Jiyeon Lee, Hyunji Lee, Jung Hyeon Yong, Donghyeon Kim, Minho Lee, Dong Woo Kang, So Yeon Jeon, Sang Joon Son, Young Min Lee, Hyug Gi Kim, Regina E.Y. Kim, Hyun Kook Lim

Research output: Contribution to journalArticlepeer-review

Abstract

Alzheimer’s disease (AD) accounts for 60–70% of the population with dementia. Mild cognitive impairment (MCI) is a diagnostic entity defined as an intermediate stage between subjective cognitive decline and dementia, and about 10–15% of people annually convert to AD. We aimed to investigate the most robust model and modality combination by combining multi-modality image features based on demographic characteristics in six machine learning models. A total of 196 subjects were enrolled from four hospitals and the Alzheimer’s Disease Neuroimaging Initiative dataset. During the four-year follow-up period, 47 (24%) patients progressed from MCI to AD. Volumes of the regions of interest, white matter hyperintensity, and regional Standardized Uptake Value Ratio (SUVR) were analyzed using T1, T2-weighted-Fluid-Attenuated Inversion Recovery (T2-FLAIR) MRIs, and amyloid PET (αPET), along with automatically provided hippocampal occupancy scores (HOC) and Fazekas scales. As a result of testing the robustness of the model, the GBM model was the most stable, and in modality combination, model performance was further improved in the absence of T2-FLAIR image features. Our study predicts the probability of AD conversion in MCI patients, which is expected to be useful information for clinician’s early diagnosis and treatment plan design.

Original languageEnglish
Article number12276
JournalScientific Reports
Volume14
Issue number1
DOIs
StatePublished - Dec 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Fingerprint

Dive into the research topics of 'A multimodal machine learning model for predicting dementia conversion in Alzheimer’s disease'. Together they form a unique fingerprint.

Cite this